Keeping one step ahead of the innovators

There can't be many people in the hedge fund industry that could comfortably say they know what makes a good investment in the realm of biotechnology.

The producers in the industry are necessarily cagey about what they are working on, and most, if not all, hedge fund managers probably wouldn't fully understand it. Most investors, that is.

Michael Walsh, founder of Kilkenny Capital Management, is different. Not just another hedge fund manager, he is a chemist with a Harvard MBA who can shed lig

To continue reading...

You must be signed in to use this feature.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: